Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
about
The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomasSerum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.Identification of epithelial ovarian tumor-specific aptamers.Multianalyte assay systems in the differential diagnosis of ovarian cancer.The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma.Serum protein profile at remission can accurately assess therapeutic outcomes and survival for serous ovarian cancer.Ascites analysis by a microfluidic chip allows tumor-cell profiling.Breast regression protein-39 (BRP-39) promotes dendritic cell maturation in vitro and enhances Th2 inflammation in murine model of asthma.From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade.Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy.A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40.Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker DiscoveryYKL-40 in the diagnosis, prediction of prognosis, and platinum sensitivity in serous epithelial ovarian cancer
P2860
Q26992102-C0A26456-BA89-4F38-90F4-BB52A0461F0BQ30434977-80F79D40-B8B8-44CF-86B5-B8CF3B20157BQ35635298-40130C93-7FAA-48CE-96FC-8217391849A6Q35854476-8079EA03-86EC-4380-B4FC-458433AEBC25Q35976828-415A71A1-871A-43E3-A6DB-7885B68659DFQ36545468-733D05D3-910F-404B-8BC6-9EDDE8C4447BQ37297487-9763DA6C-F35B-4584-8CB5-62B672B00B09Q37409535-6F13B02E-A561-4E64-A3DE-15EAA00CA3C2Q37727177-E3E6A592-A828-46D6-A780-27A1BCC4292EQ38052927-9612016E-AD81-4598-99C6-FB5A2C165042Q38184632-BFE09820-61A0-4C77-ACF9-6550B591E3FBQ38653169-50E46477-60BA-4288-BEF0-C421FDC9C822Q41564973-ECE325A1-34A3-4177-8B17-0BABE457265AQ47254535-972F13EC-D202-4674-BE19-A7F5214684A5Q57173976-43A9BFC0-B6F8-49AD-A59F-913EBE07DDA5Q58767748-32F9080B-1F9C-43B2-9576-B9426F5D39AF
P2860
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
@ast
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
@en
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
@nl
type
label
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
@ast
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
@en
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
@nl
prefLabel
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
@ast
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
@en
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
@nl
P2093
P2860
P3181
P1433
P1476
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers
@en
P2093
Greg P Bertenshaw
James P Mapes
Karri L Michael-Ballard
Laurie L Stephen
Partha Seshaiah
Tzong-Hao Chen
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0029533
P407
P577
2011-01-01T00:00:00Z